tocophersolan: Clinical Trials

6 trials of tocophersolan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 withdrawn. 3 Phase 1, 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 22Completed 1, Withdrawn 1
Phase 31Completed 1

Follow tocophersolan: new trials by email Literature Review of tocophersolan trials Research Report on tocophersolan

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Use of Tocofersolan (VedropĀ®) to Prevent or Treat Refractive Vitamin E Deficiency in Infants and Children
Tocofersolan - Short Bowel Syndrome, Vitamin E Deficiency
Phase 2WithdrawnBoston Children's Hospital2020-12-012020-05-13
Bioavailability Study of Oral OZ439 Prototype Granule Formulations Administered With Piperaquine Phosphate (PQP) Tablets
OZ439 + TPGS, OZ439 Prototype 1, OZ439 Prototype 3 - Malaria
Phase 1CompletedMedicines for Malaria Venture482015-04-012016-02-08
Open Label Pharmacokinetic Study of OZ439 and Piperaquine on Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in Healthy Volunteers
1440mg PQP tablets, 960mg PQP tablets, 800mg OZ439 + TPGS - Malaria
Phase 1CompletedMedicines for Malaria Venture552013-10-012015-05-08
Vitamin E Supplement in Patients With Cirrhosis and Acanthocytosis
Vitamin E supplement (tocofersolan) - Cirrhosis
Phase 2CompletedUniversity Hospital, Geneva272011-11-012014-03-18
Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention
Tocofersolan, tocopherol alpha, Tocofersolan and tocopherol alpha - Hypobetalipoproteinemias
Phase 3CompletedHospices Civils de Lyon142011-10-012025-08-22
Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide
Oral Etoposide, Oral 9-Nitrocamptothecin - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedH. Lee Moffitt Cancer Center and Research Institute442000-06-012012-09-26

Conditions studied

Malaria (2)  ·  Fibrosis (1)  ·  Hypobetalipoproteinemias (1)  ·  Short Bowel Syndrome (1)  ·  Vitamin E Deficiency (1)

Sponsors

Medicines for Malaria Venture (2)  ·  Boston Children's Hospital (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  Hospices Civils de Lyon (1)  ·  University Hospital, Geneva (1)

Countries

United Kingdom (2)  ·  France (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Daniel M. Sullivan, M.D. (1)  ·  Fiona Macintyre, PhD (1)  ·  Ulrike Lorch, MD FRCA FFPM (1)

Results publications

PMID 21324480, PMID 30021760